| Accession Number: | 0001209191-23-021136 |
| Date: | 2023-03-24 |
| Issuer: | XENON PHARMACEUTICALS INC. (XENE) |
| Original Submission Date: |
KENNEY CHRISTOPHER JOHN
200 - 3650 GILMORE WAY
BURNABY, A1 V5G 4W8
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON SHARES | 2023-03-24 | S | 700 | d | $35.01 | 0 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|
| ID | footnote |
|---|
